Roche Pays $220 Million For Blood Testing Innovator

Law360, New York (July 02, 2013, 4:40 PM ET) -- Swiss pharmaceutical titan Roche Holding AG announced Tuesday that it will shell out $220 million to acquire Constitution Medical Investors Inc., which is developing a new testing system for blood diseases.

Roche said that more payments could follow if certain incentives are met, but did not provide any details. It made the purchase in an effort to bolster its competitive position in the laboratory hematology testing business.

“With this acquisition, we will further strengthen our commitment to hematology and drive toward integrated laboratory solutions with innovative products...
To view the full article, register now.